
Bioorganic and Medicinal Chemistry Letters p. 3583 - 3588 (1998)
Update date:2022-08-03
Topics:
Ambler, John
Baker, Emma
Brown, Lyndon
Butler, Paul
Farr, Dave
Dunnet, Karen
Le Grand, Darren
Janus, Diana
Jones, Darryl
Menear, Keith
Mercer, Mark
Smith, Garrick
Talbot, Mark
Tweed, Morris
The chemical optimisation of CGH1668 1 is described employing an in vivo model of absorption to determine the influence on bioavailability of single point modifications to five key molecular templates. The discovery of an orally bioavailable and selective thrombin inhibitor, 24, highlights the utility of this approach.
View MoreZhejiang Rongkai Chemical Technology Co.,Ltd.
Contact:+86-578-8185786
Address:Shangjiang Industrial Zone,Suichang
Springchem New Material Technology Co.,Limited
website:http://www.spring-chem.com
Contact:86-21-62885108
Address:602B, Building 1, No. 641, Tianshan Road
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Tangshan Moneide Trading Co., Ltd.
Contact:+86-315-8309571
Address:2-7-420 Jidong Building Materials Commercial Center, Tangshan, Hebei, 064000 China
Tianjin Pharmacn Medical Technology Co.,Ltd.
Contact:86-22-60122566ext.866(English),23359620
Address:Green Industrial Base, 6 Haitaifazhan Sixth Rd., Huayuan Industrial Area, Tianjin, 300384, China
Doi:10.1016/j.tet.2010.05.054
(2010)Doi:10.1039/a705571d
(1997)Doi:10.1007/BF02291796
(1997)Doi:10.1021/jm00301a034
(1969)Doi:10.1039/DT9950002923
(1995)Doi:10.1021/jo060129c
(2006)